These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7423177)

  • 1. [Comparative evaluation of the anti-hypertensive effect of moduretic and thiazides].
    Rosenfeld JB
    Schweiz Med Wochenschr; 1980 Oct; 110(41):1498-501. PubMed ID: 7423177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-hypertensive effect of timolol maleate (blocadren) in gradated combination with a diuretic].
    Vorburger C
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1474-81. PubMed ID: 1013666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
    Corea L; Bentivoglio M; Verdecchia P
    Int J Clin Pharmacol Res; 1983; 3(5):367-70. PubMed ID: 6678830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
    Jaffé G; Grimshaw JJ; Vallé-Jones JC; Warnock JM
    Practitioner; 1982 Feb; 226(1364):355-8. PubMed ID: 7088834
    [No Abstract]   [Full Text] [Related]  

  • 5. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a fixed ratio combination of hydrochlorothiazide, amiloride and timolol ('Moducren') given once versus twice daily in mild to moderate hypertension.
    Young JH; VandenBurg MJ; Isitt VL; Currie WJ
    Pharmatherapeutica; 1984; 4(1):64-8. PubMed ID: 6504947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moducrin--a new combined preparation in the treatment of hypertension (author's transl)].
    Prachar H; Nobis H; Pollak H; Enenkel W
    Wien Klin Wochenschr; 1981 Aug; 93(15):489-92. PubMed ID: 7303690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE
    Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of moduretic and hydrochlorothiazide in the treatment of hypertension in African patients.
    Salako LA; Falase AO
    East Afr Med J; 1973 Jan; 50(1):38-47. PubMed ID: 4720446
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of moduretic in the treatment of arterial hypertension.
    Salako LA; Falase AO
    Niger Med J; 1973 Jul; 3(3):150-5. PubMed ID: 16366351
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of the diuretic preparation moduretic].
    Matthew G
    Farmakol Toksikol; 1978; 41(6):701-4. PubMed ID: 720583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Moduretic in ambulatory treatment of hypertension].
    Piwowarska W; Bielecki A
    Pol Tyg Lek; 1977 Aug; 32(32):1253-4. PubMed ID: 896585
    [No Abstract]   [Full Text] [Related]  

  • 18. The antihypertensive and biochemical effects of hydrochlorothiazide/amiloride (Moduretic) versus chlorthalidone.
    van Soeren F
    J Int Med Res; 1980; 8(2):132-5. PubMed ID: 6989682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE; Arr S; Tait D
    Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.